TITLE:
Buprenorphine and Naloxone Combination Study - 10

CONDITION:
Heroin Dependence

INTERVENTION:
Buprenorphine/naloxone

SUMMARY:

      The purpose of this study is to examine pharmacokinetics and dose proportionality of
      sublingual tablets containing varying doses of buprenorphine and naloxone.
    

DETAILED DESCRIPTION:

      The objective of this study is to examine pharmacokinetics and dose proportionality of
      sublingual tablets containing varying doses of buprenorphine and naloxone.
    

ELIGIBILITY:
Gender: All
Age: 21 Years to 50 Years
Criteria:

        Inclusion Criteria:

        Male/Female between the ages of 21 and 45. Within 15% of ideal body weight. No oral
        pathology that would interfere with the sublingual absorption of the medication.
        Experienced in the use of opiates but not dependent.

        Exclusion Criteria:

        LFT's exceeding than 3x's normal. History of seizure. Opiate dependent.
      
